Remove 2007 Remove Bipolar disorder Remove Hospitality
article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). million in consulting fees from drug makers from 2000 to 2007.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolar disorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.